Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function - PubMed

Affiliations

• PMID: 16107868
• DOI: 10.1038/sj.ijir.3901380

Randomized Controlled Trial

Early use of vacuum constriction device following radical prostatectomy facilitates early sexual activity and potentially earlier return of erectile function

R Raina et al. Int J Impot Res. 2006 Jan-Feb.

Abstract

To assess the efficacy of vacuum constriction devices (VCD) following radical prostatectomy (RP) and determine whether early use of VCD facilitates early sexual activity and potentially earlier return of erectile function. This prospective study consisted of 109 patients who underwent nerve-sparing (NS) or non-nerve-sparing (NNS) RP between August 1999 and October 2001 and developed erectile dysfunction following surgery. The patients were randomized to VCD use daily for 9 months (Group 1, N=74) or observation without any erectogenic treatment (Group 2, N=35). Treatment efficacy was analyzed by responses to the Sexual Health Inventory of Men (SHIM) (abridged 5-item International Index of Erectile Function (IIEF-5)), which were stratified by the NS status. Patient outcome regarding compliance, change in penile length, return of natural erection, and ability for vaginal intercourse were also assessed. The mean patient age was 58.2 years, and the minimum follow-up was 9 months. Use of VCD began at an average of 3.9 weeks after RP. In Group 1, 80% (60/74) successfully used their VCD with a constriction ring for vaginal intercourse at a frequency of twice/week with an overall spousal satisfaction rate of 55% (33/60). In all, 19 of these 60 patients (32%) reported return of natural erections at 9 months, with 10/60 (17%) having erections sufficient for vaginal intercourse. The abridged IIEF-5 score significantly increased after VCD use in both the NS and NNS groups. After a mean use of 3 months, 14/74 (18%) discontinued treatment. In Group 2, 37% (13/35) of patients regained spontaneous erections at a minimum follow-up of 9 months after surgery. However, only four of these patients (29%) had erections sufficient for successful vaginal intercourse and rest of patients (71%) sought adjuvant treatment. Of the 60 successful users, 14 (23%) reported a decrease in penile length and circumference at 9 months (range, 4-8 months) compared to 12/14 (85%) among the nonresponders. However, in control group 22/35 reported decrease in penile length and circumference. Early use of VCD following RP facilitates early sexual intercourse, early patient/spousal sexual satisfaction, and potentially an earlier return of natural erections sufficient for vaginal penetration.

Similar articles

• The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity.

  Raina R, Pahlajani G, Agarwal A, Zippe CD. Raina R, et al. BJU Int. 2007 Dec;100(6):1317-21. doi: 10.1111/j.1464-410X.2007.07124.x. Epub 2007 Sep 11. BJU Int. 2007. PMID: 17850385

• Sildenafil citrate and vacuum constriction device combination enhances sexual satisfaction in erectile dysfunction after radical prostatectomy.

  Raina R, Agarwal A, Allamaneni SS, Lakin MM, Zippe CD. Raina R, et al. Urology. 2005 Feb;65(2):360-4. doi: 10.1016/j.urology.2004.09.013. Urology. 2005. PMID: 15708053 Clinical Trial.

• A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy.

  Köhler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P, Makhlouf A, Ryndin I, Canales BK, Weiland D, Nakib N, Ramani A, Anderson JK, Monga M. Köhler TS, et al. BJU Int. 2007 Oct;100(4):858-62. doi: 10.1111/j.1464-410X.2007.07161.x. BJU Int. 2007. PMID: 17822466 Clinical Trial.

• The role of vacuum erection devices in penile rehabilitation after radical prostatectomy.

  Lehrfeld T, Lee DI. Lehrfeld T, et al. Int J Impot Res. 2009 May-Jun;21(3):158-64. doi: 10.1038/ijir.2009.3. Epub 2009 Feb 19. Int J Impot Res. 2009. PMID: 19225465 Review.

Cited by

• Erectile dysfunction.

  Yafi FA, Jenkins L, Albersen M, Corona G, Isidori AM, Goldfarb S, Maggi M, Nelson CJ, Parish S, Salonia A, Tan R, Mulhall JP, Hellstrom WJ. Yafi FA, et al. Nat Rev Dis Primers. 2016 Feb 4;2:16003. doi: 10.1038/nrdp.2016.3. Nat Rev Dis Primers. 2016. PMID: 27188339 Free PMC article. Review.

• [Prostate carcinoma and erectile dysfunction. Which therapy when?].

  Sperling H, Noldus J. Sperling H, et al. Urologe A. 2003 Oct;42(10):1351-6. doi: 10.1007/s00120-003-0416-2. Urologe A. 2003. PMID: 14569384 German.

• Vacuum therapy in penile rehabilitation after radical prostatectomy: review of hemodynamic and antihypoxic evidence.

  Qian SQ, Gao L, Wei Q, Yuan J. Qian SQ, et al. Asian J Androl. 2016 May-Jun;18(3):446-51. doi: 10.4103/1008-682X.159716. Asian J Androl. 2016. PMID: 26289397 Free PMC article. Review.

• Comparison of the efficacy of the early LI-SWT plus daily tadalafil with daily tadalafil only as penile rehabilitation for postprostatectomy erectile dysfunction.

  Jang SW, Lee EH, Chun SY, Ha YS, Choi SH, Lee JN, Kim BS, Kim HT, Kim SH, Kim TH, Yoo ES, Chung JW, Kwon TG. Jang SW, et al. Int J Impot Res. 2023 Aug;35(5):447-453. doi: 10.1038/s41443-022-00560-w. Epub 2022 Mar 28. Int J Impot Res. 2023. PMID: 35347300 Free PMC article.

• Penile rehabilitation following prostate cancer treatment: review of current literature.

  Clavell-Hernandez J, Wang R. Clavell-Hernandez J, et al. Asian J Androl. 2015 Nov-Dec;17(6):916-22; discussion 921. doi: 10.4103/1008-682X.150838. Asian J Androl. 2015. PMID: 25851656 Free PMC article. Review.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal